Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07160933

Development of a Psychosocial Intervention to Reduce Post Traumatic Stress in Young Adult Survivors of Cancer

The goal of this study is to develop a virtual group intervention to address post-traumatic stress related to cancer in young adult cancer survivors (YACs, aged 18-39). The study team will do this by integrating evidence-guided treatments and expert clinician feedback (N=10) on the content, delivery, and structure of the intervention. Next, the study team will refine this intervention through a pilot trial with a group of YACs (N=80).

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–39 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mass General Cancer Center

Boston, Massachusetts, 02114, United States

Location contact

Blane Zhu, B.S.

CONTACT

[email protected]

(617) 726-5130

Zeba N Ahmad, Ph.D.

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

To be eligible for this study, participants will be:

  • Currently aged between 18 - 39;
  • Currently receiving or having completed treatment for cancer at the Mass General Cancer Institute within the past 5 years;
  • Reporting a score denoting at least mild symptoms of PTSD on the Post-traumatic Stress Checklist 5 (PCL-5);
  • English-speaking;
  • Have access to a device with audio/video capabilities to complete virtual intervention sessions.

Exclusion criteria

  • Unable to provide verbal consent
  • Reporting active symptoms of psychosis that preclude safe participation.

Treatment and study plan

Psychosocial Intervention for Cancer-Related Post-Traumatic Stress in Young Adults

Behavioral

A new group-based virtual intervention to address post-traumatic stress related to cancer in YACs, integrating evidence-guided treatments from Cognitive Processing Therapy and Mind-Body Resiliency interventions.

Primary outcomes

  1. Intervention Feasibility: Percent of Identified Prospective Participants Who Enroll

    Time frame: Post-treatment completion (enrollment to treatment completion is approximately 3 months)

    Percent of eligible participants who were offered participation and who enroll in the study by completing consent and baseline assessment.

  2. Intervention Feasibility: Proportion of Participants Completing the Program

    Time frame: Post-treatment completion (enrollment to treatment completion is approximately 3 months)

    Percent of enrolled participants who complete the program, defined as completing 6 out of 8 sessions.

  3. Intervention Acceptability

    Time frame: Post-treatment completion (enrollment to treatment completion is approximately 3 months)

    Acceptability will be assessed by the Client Satisfaction Questionnaire (CSQ-8). The intervention study will be considered acceptable if ≥80% of participants rate it as acceptable (defined as a CSQ-8 score ≥20).

Study contacts

Contact information is provided by the study sponsor or research team.

Xinghan Zhu, B.S.

CONTACT

[email protected]

617-724-7593

Zeba N Ahmad, Ph.D.

CONTACT

[email protected]

617-724-1586

Sponsors and collaborators

Lead sponsor

Zeba Ahmad, Ph.D.

Other

Collaborators

  • American Cancer Society, Inc.

Registry information

Official study title

Adaptation and Refinement of a Psychosocial Intervention to Reduce Post-Traumatic Stress in Young Adult Survivors of Cancer

Important dates

Study start
2026
Primary completion
2030
Study completion
2030
First posted
Sep 8, 2025
Registry last updated
Mar 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.